» Articles » PMID: 36793210

Comparative Analysis of CRISPR Off-target Discovery Tools Following Ex vivo Editing of CD34 Hematopoietic Stem and Progenitor Cells

Overview
Journal Mol Ther
Publisher Cell Press
Date 2023 Feb 16
PMID 36793210
Authors
Affiliations
Soon will be listed here.
Abstract

While a number of methods exist to investigate CRISPR off-target (OT) editing, few have been compared head-to-head in primary cells after clinically relevant editing processes. Therefore, we compared in silico tools (COSMID, CCTop, and Cas-OFFinder) and empirical methods (CHANGE-Seq, CIRCLE-Seq, DISCOVER-Seq, GUIDE-Seq, and SITE-Seq) after ex vivo hematopoietic stem and progenitor cell (HSPC) editing. We performed editing using 11 different gRNAs complexed with Cas9 protein (high-fidelity [HiFi] or wild-type versions), then performed targeted next-generation sequencing of nominated OT sites identified by in silico and empirical methods. We identified an average of less than one OT site per guide RNA (gRNA) and all OT sites generated using HiFi Cas9 and a 20-nt gRNA were identified by all OT detection methods with the exception of SITE-seq. This resulted in high sensitivity for the majority of OT nomination tools and COSMID, DISCOVER-Seq, and GUIDE-Seq attained the highest positive predictive value (PPV). We found that empirical methods did not identify OT sites that were not also identified by bioinformatic methods. This study supports that refined bioinformatic algorithms could be developed that maintain both high sensitivity and PPV, thereby enabling more efficient identification of potential OT sites without compromising a thorough examination for any given gRNA.

Citing Articles

Dual α-globin-truncated erythropoietin receptor knockin restores hemoglobin production in α-thalassemia-derived erythroid cells.

Chu S, Soupene E, Sharma D, Sinha R, McCreary T, Hernandez B Cell Rep. 2025; 44(1):115141.

PMID: 39754719 PMC: 11837859. DOI: 10.1016/j.celrep.2024.115141.


Efficient and correction of hemoglobin Constant Spring mutation by prime editing in human hematopoietic cells.

Shao C, Liu Q, Xu J, Zhang J, Zhang C, Xin Y Mol Ther Nucleic Acids. 2024; 35(4):102371.

PMID: 39640014 PMC: 11617223. DOI: 10.1016/j.omtn.2024.102371.


Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients.

Montepeloso A, Mattioli D, Pellin D, Peviani M, Genovese P, Biffi A Nat Commun. 2024; 15(1):10192.

PMID: 39587072 PMC: 11589136. DOI: 10.1038/s41467-024-54515-4.


Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0.

Assa G, Kalter N, Rosenberg M, Beck A, Markovich O, Gontmakher T Nucleic Acids Res. 2024; 52(16):e78.

PMID: 39077930 PMC: 11381363. DOI: 10.1093/nar/gkae651.


An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation.

Porreca I, Blassberg R, Harbottle J, Joubert B, Mielczarek O, Stombaugh J Mol Ther. 2024; 32(8):2692-2710.

PMID: 38937969 PMC: 11405993. DOI: 10.1016/j.ymthe.2024.06.033.


References
1.
Shrivastav M, De Haro L, Nickoloff J . Regulation of DNA double-strand break repair pathway choice. Cell Res. 2007; 18(1):134-47. DOI: 10.1038/cr.2007.111. View

2.
Kim M, Yu K, Kenderian S, Ruella M, Chen S, Shin T . Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell. 2018; 173(6):1439-1453.e19. PMC: 6003425. DOI: 10.1016/j.cell.2018.05.013. View

3.
Ihry R, Worringer K, Salick M, Frias E, Ho D, Theriault K . p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med. 2018; 24(7):939-946. DOI: 10.1038/s41591-018-0050-6. View

4.
Tsai S, Zheng Z, Nguyen N, Liebers M, Topkar V, Thapar V . GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2014; 33(2):187-197. PMC: 4320685. DOI: 10.1038/nbt.3117. View

5.
Mittelman D, Wilson J . The fractured genome of HeLa cells. Genome Biol. 2013; 14(4):111. PMC: 3663084. DOI: 10.1186/gb-2013-14-4-111. View